33 results
8-K
EX-1.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
by a subsequent submission); (ii) the Company has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation … , to the Company’s knowledge, is any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened; (iii
8-K
EX-1.1
q475 012u3mjsgu1h
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-1.1
z79ux8kz
16 May 23
Other Events
5:21pm
8-K
EX-99.1
uvaicr
10 Apr 23
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
7:45am
S-3
EX-4.4
q0fmmpk7
9 Nov 22
Shelf registration
7:53am
S-3
EX-4.5
ln7m4xyfuxu8t98pxe9s
9 Nov 22
Shelf registration
7:53am
8-K
EX-10.1
bj1xh1z9
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
10-K
pn76b 5yfan79
9 Mar 22
Annual report
7:30am
8-K
EX-10.1
kr5 nqe6geqlam5tpy6
2 Dec 21
Entry into a Material Definitive Agreement
7:31am
424B4
3sxfwhrb63yxma53e
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-1/A
EX-1.1
vvt j93inqhdp
30 Apr 21
IPO registration (amended)
5:00pm